Australian Clinical Labs Ltd (ASX:ACL) announced that it has successfully completed the $70m acquisition of Medlab Pathology, a leading Australian privately-owned independent pathology provider, with two laboratories and 288 collection centres across NSW and QLD. Since announcing it had entered into a binding agreement to purchase Medlab Pathology on November 15, 2021, regulatory approvals have been achieved, conditions precedent have been met and the completion has now occurred.
Following the announcement, shares of Australian Clinical Labs Ltd rose 1.42% to $4.99/share.